4 free views remaining today
developmental and epileptic encephalopathy 9
ICD-10 Codes
Related ICD-10:
Description
Developmental and Epileptic Encephalopathy (DEE)
Developmental and epileptic encephalopathy (DEE) is a group of severe neurological disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities. These conditions are associated with developmental impairments or intellectual disabilities, which can range from mild to severe.
Key Features:
- Early-onset seizures: DEEs are typically characterized by the onset of seizures in infancy or early childhood.
- Severe epileptic activity: Patients with DEE often experience frequent and severe epileptiform activity on EEG recordings.
- Developmental impairments: DEEs are associated with various degrees of developmental delay, intellectual disability, or cognitive impairment.
Types of DEE:
While there is no clear classification system for DEEs, they can be broadly categorized into several subtypes based on their clinical presentation and underlying causes. These include:
- Infantile spasms: A type of seizure disorder characterized by brief, sudden contractions of the muscles.
- West syndrome: A rare condition marked by infantile spasms, developmental delay, and EEG abnormalities.
Causes and Risk Factors:
The exact causes of DEEs are still not fully understood. However, research suggests that genetic mutations, environmental factors, and perinatal complications may contribute to the development of these conditions.
- Genetic predisposition: Many cases of DEE have been linked to genetic mutations or chromosomal abnormalities.
- Environmental factors: Exposure to toxins, infections, or other environmental stressors during pregnancy or early childhood may increase the risk of developing a DEE.
References:
- [1] Developmental and epileptic encephalopathies (DEEs) are a heterogeneous group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities. [7]
- [2] DEEs are associated with various degrees of developmental delay, intellectual disability, or cognitive impairment. [3]
- [3] Infantile spasms are a type of seizure disorder characterized by brief, sudden contractions of the muscles. [4]
- [4] West syndrome is a rare condition marked by infantile spasms, developmental delay, and EEG abnormalities. [5]
- [5] Genetic mutations or chromosomal abnormalities may contribute to the development of DEEs. [6]
- [6] Environmental factors such as exposure to toxins or infections during pregnancy or early childhood may increase the risk of developing a DEE. [8]
- [7] Developmental and epileptic encephalopathies (DEEs) are characterized by early-onset, often severe epileptic seizures and EEG abnormalities. [8]
- [8] DEEs are associated with developmental impairments or intellectual disabilities, which can range from mild to severe. [2]
Additional Characteristics
- Developmental and epileptic encephalopathy (DEE) is a group of severe neurological disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities.
- These conditions are associated with developmental impairments or intellectual disabilities, which can range from mild to severe.
- Infantile spasms are a type of seizure disorder characterized by brief, sudden contractions of the muscles.
- West syndrome is a rare condition marked by infantile spasms, developmental delay, and EEG abnormalities.
- Genetic mutations or chromosomal abnormalities may contribute to the development of DEEs.
- Environmental factors such as exposure to toxins or infections during pregnancy or early childhood may increase the risk of developing a DEE.
Signs and Symptoms
Common Signs and Symptoms
Developmental and Epileptic Encephalopathy (DEE) is a severe form of epilepsy that affects infants and young children. The clinical presentation typically includes early onset epilepsy with developmental impairment and abnormal EEG.
- Early Onset Epilepsy: Tonic spasms within the first 3 months of life, which can be generalized or focal.
- Developmental Impairment: Significant delays in cognitive, motor, and language development.
- Abnormal EEG: Hypsarrhythmia, a characteristic pattern on electroencephalogram (EEG) readings.
Other signs and symptoms may include:
- Seizures: Frequent seizures of multiple types, including tonic-clonic, myoclonic, and atonic seizures.
- Intellectual Disability: Significant cognitive impairment, often with delayed speech development.
- Behavioral Issues: Developmental delays and behavioral problems, such as hyperactivity and aggression.
These symptoms can vary in severity and may be accompanied by other signs of neurological dysfunction, including cerebral atrophy, hypomyelination, and ventriculomegaly. Early diagnosis and treatment are crucial to manage the condition effectively and improve outcomes for affected children. [1][2][3][4][5]
Additional Symptoms
- Seizures
- Intellectual Disability
- Behavioral Issues
- Early Onset Epilepsy
- Developmental Impairment
- Abnormal EEG
Diagnostic Tests
Diagnostic Tests for Developmental and Epileptic Encephalopathy (DEE)
Developmental and Epileptic Encephalopathy (DEE) is a group of severe epilepsies characterized by seizures, which are often resistant to treatment. Accurate diagnosis is crucial for effective management of DEE. The following diagnostic tests are commonly used to identify the causes of DEE:
- Electroencephalogram (EEG): An EEG is a critical test in diagnosing DEE, particularly during sleep and wake states [1]. It helps identify abnormal electrical activity in the brain.
- Magnetic Resonance Imaging (MRI): MRI scans are used to rule out other conditions that may be causing seizures. They can also help identify structural abnormalities in the brain [8].
- Genetic testing: Genetic testing, such as next-generation sequencing (NGS), is a valuable diagnostic tool for detecting gene mutations associated with DEE [6]. This test can help identify the underlying cause of the condition.
- Molecular testing: Molecular testing can facilitate the diagnosis of the aetiology of DEE. Epilepsy syndromes are characterized by age of onset, seizure types, and other factors [9].
These diagnostic tests are essential for accurate diagnosis and effective management of DEE. Early identification of the underlying cause can lead to targeted treatment and improved outcomes.
References:
[1] P Jain (2013) - The diagnosis of these epileptic encephalopathies begins with an EEG which should include both the sleep and wake states. [6] YT Chang (2023) - Among the multiple genetic tests available today, NGS is considered a valuable and dependable diagnostic tool for detecting gene mutations in DEE. [8] Diagnostic tests used to identify causes include electroencephalogram (EEG) and magnetic resonance imaging (MRI). [9] Molecular testing can facilitate the diagnosis of the aetiology of the DEE.
Additional Diagnostic Tests
- Magnetic Resonance Imaging (MRI)
- Genetic testing
- Electroencephalogram (EEG)
- Molecular testing
Treatment
Treatment Options for Developmental and Epileptic Encephalopathy (DEE)
Developmental and epileptic encephalopathies (DEEs) are rare neurodevelopmental disorders characterized by early-onset and often intractable seizures and developmental delays. The treatment of DEE is challenging, but various pharmacological and non-pharmacological interventions can be employed to manage the condition.
- Anticonvulsant medications: First-line treatments for DEE include anticonvulsant medications such as phenobarbital, valproate, and levetiracetam. These medications aim to control seizures and prevent their progression.
- Other pharmacological interventions: In some cases, other medications like benzodiazepines, corticosteroids, or immunomodulatory agents may be used to manage specific symptoms or complications associated with DEE.
- Non-pharmacological interventions: Non-invasive treatments such as vagus nerve stimulation (VNS) and ketogenic diet have been explored as potential adjunctive therapies for DEE. These approaches aim to modulate brain activity and reduce seizure frequency.
Challenges in Treating DEE
The treatment of DEE is often hindered by the following factors:
- Seizure resistance: Many patients with DEE experience seizures that are resistant to anticonvulsant medications, making it challenging to achieve effective control.
- Developmental delays: The developmental delays associated with DEE can make it difficult to implement and monitor treatment plans.
- Comorbidities: Patients with DEE often have comorbid conditions such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), or other neurodevelopmental disorders, which can complicate treatment.
Emerging Therapies
Research is ongoing to explore new therapeutic approaches for DEE. Some emerging therapies include:
- Gene therapy: Gene therapy aims to modify the genetic mutations responsible for DEE, potentially leading to improved seizure control and developmental outcomes.
- Stem cell therapy: Stem cell therapy involves using stem cells to repair or replace damaged brain tissue, which may help alleviate symptoms associated with DEE.
References
- by GJ Sills · 2023 · Cited by 9 — Developmental and epileptic encephalopathies (DEEs) are rare neurodevelopmental disorders characterised by early-onset and often intractable seizures and developmental delays.
- [9]
Recommended Medications
- benzodiazepines
- corticosteroids
- immunomodulatory agents
- valproate
- Valproate
- phenobarbital
- Phenobarbital
- levetiracetam
- Levetiracetam
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses of Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathy (DEE) is a complex condition that requires a comprehensive differential diagnosis to accurately diagnose and treat. The following conditions are considered in the differential diagnoses for DEE:
- Early Myoclonic Encephalopathy: This condition is characterized by early onset seizures, developmental delay, and myoclonic jerks.
- West Syndrome: Also known as infantile spasms, this condition is marked by a specific type of seizure that occurs in infants, often accompanied by developmental delays.
- Other Early Onset Epileptic Encephalopathies: These include conditions such as Othahara syndrome, early myoclonic encephalopathy, and others.
These differential diagnoses are important to consider when evaluating patients with DEE, as they can have overlapping symptoms and require distinct treatment approaches. Accurate diagnosis is crucial for providing effective care and improving outcomes for individuals with DEE.
References:
- [1] - The electroencephalographs (EEGs) in children with DEEs are typically very abnormal, showing diffuse slowing of the background, and frequent seizure discharges.
- [7] - Differential diagnoses include other epileptic encephalopathies such as early myoclonic encephalopathy, West syndrome (see these terms) and other early onset ...
- [9] - An underlying etiology drives developmental outcomes directly (developmental encephalopathy) and also results in epilepsy. The abnormal ...
Additional Differential Diagnoses
- developmental and epileptic encephalopathy 58
- developmental and epileptic encephalopathy 48
- developmental and epileptic encephalopathy 28
- developmental and epileptic encephalopathy 1
- developmental and epileptic encephalopathy 94
- Other Early Onset Epileptic Encephalopathies
- West syndrome
- N syndrome
- early myoclonic encephalopathy
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1809
- owl#annotatedSource
- t345313
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0060848
- core#notation
- DOID:0060848
- oboInOwl#hasDbXref
- ORDO:101039
- oboInOwl#hasExactSynonym
- Juberg Hellman syndrome
- rdf-schema#label
- developmental and epileptic encephalopathy 9
- IAO_0000115
- A developmental and epileptic encephalopathy characterized by seizure onset in infancy and mild to severe intellectual impairment in females that has_material_basis_in heterozygous mutation in the gene encoding protocadherin-19 (PCDH19) on chromosome Xq22.
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- rdf-schema#subClassOf
- t345312
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000146
- relatedICD
- http://example.org/icd10/G93.45
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.